Overview
Dr. Strickland specializes in cytopathology and women's and perinatal surgical pathology. His areas of interest include epithelial and mesenchymal gynecologic neoplasia and fine needle aspiration cytology.
Current Appointments & Affiliations
Adjunct Associate Professor of Pathology
·
2022 - Present
Pathology,
Clinical Science Departments
Member of the Duke Cancer Institute
·
2018 - Present
Duke Cancer Institute,
Institutes and Centers
Recent Publications
Molecular classification of endometrial cancers (EC) and association with relapse-free survival (RFS) and overall survival (OS) outcomes: Ancillary analysis of GOG-0258.
Journal Article Gynecol Oncol · February 2025 PURPOSE: Determine if molecular classification using mismatch repair (MMR) and p53 protein expression predicts recurrence-free survival (RFS) and overall survival (OS) in endometrial cancer (EC) patients treated with chemotherapy and radiation (CRT) versus ... Full text Link to item CiteAnalysis of real world FRα testing in ovarian, fallopian tube, and primary peritoneal cancers.
Journal Article Gynecol Oncol · January 2025 BACKGROUND: Epithelial ovarian cancer (EOC) remains a significant challenge in gynecologic oncology, particularly in the context of platinum-resistant disease. Mirvetuximab soravtansine (MIRV), was approved after trials revealed favorable response and surv ... Full text Link to item CiteFrom tissue-specific to tissue-agnostic: HER2 overexpression and the rise of antibody-drug conjugates.
Journal Article Front Oncol · 2025 The growing importance of HER2 expression as a biomarker across multiple cancers is largely driven by advances in HER2-directed antibody-drug conjugates. The recent approval of trastuzumab deruxtecan (T-DXd) as a tumor-agnostic therapy has revolutionized t ... Full text Link to item CiteRecent Grants
Duke University Maternal-Fetal Medicine Units (MFMU) Network Clinical Center
ResearchCollaborating Investigator · Awarded by Eunice Kennedy Shriver National Institute of Child Health and Human Development · 2023 - 2030Molecular classification of endometrial advanced stage cancers and association with survival outcomes: Ancillary analysis of GOG-0258
ResearchCo Investigator · Awarded by American Association of Obstetricians and Gynecologists Foundation · 2021 - 2022Are ESR1 mutations associated with shorter progression free survival in copy number-low endometrial adenocarcinomas?
ResearchPrincipal Investigator · Awarded by Foundation for Women's Cancer · 2020 - 2022View All Grants
Education, Training & Certifications
Medical University of South Carolina, College of Medicine ·
2013
MD./PhD.
College of Charleston ·
2005
B.A.
College of Charleston ·
2005
B.S.
College of Charleston ·
2005
B.S.